Dr Reddy s lines up Rs 1,000 crore capex for current fiscal year
SECTIONS
Last Updated: May 24, 2021, 01:04 PM IST
Share
Agencies
The company remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official.
INSIGHTS
NSE
Explore Now
NEW DELHI: Drug major Dr Reddy s Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official.
The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal. The Capex will be around the same numbers, maybe a bit higher if everything goes through, Dr Reddy s Laboratories CEO Erez Israeli said in an analyst call.